Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Kiora Pharmaceuticals has received regulatory approval to initiate KLARITY, a Phase 2 clinical trial evaluating KIO-104 as a novel treatment for retinal macular edema.
Kiora Pharmaceuticals reported a strong financial position with $29.0 million in cash and equivalents, extending the cash runway into 2027.
Kiora Pharmaceuticals has received regulatory approval to commence the ABACUS-2 Phase 2 clinical trial of KIO-301 for retinitis pigmentosa.
Kiora Pharmaceuticals received IND approval to begin a Phase 2 trial (ABACUS-2) of KIO-301 for vision restoration in retinitis pigmentosa patients.